Strategic Acquisition Dosist was fully acquired by Final Bell Corp in January 2024, positioning it for accelerated growth and expanded market access. This presents opportunities for sales partners to collaborate on scaling distribution channels and entering new geographic regions.

Expanding Market Reach Recent expansion into the East Coast with the opening of offices in Garden City, New York, indicates a strategic move to penetrate national markets. Business development efforts can capitalize on this geographic growth by offering tailored marketing and distribution solutions.

Innovative Product Portfolio Dosist develops targeted, dose-controlled wellness and cannabis products, including gummies and CBD lines, that appeal to health-conscious consumers seeking precision and predictability. Sales opportunities exist in partnering to promote these cutting-edge formulations across new retail channels.

Industry Recognition Recognized by Time Magazine and Fast Company as an innovative leader, dosist’s reputation enhances its credibility and opens doors for collaboration with premium retailers and health-focused brands seeking trusted wellness solutions.

Financial and Growth Potential With revenues estimated between $1M and $10M and ongoing product innovation, dosist is positioned for growth in the competitive wellness and cannabis markets. Offering support for expansion initiatives can help accelerate their market penetration and revenue growth.